Log in
Enquire now
HiberCell

HiberCell

HiberCell is a New York-based biotechnology company developing therapeutics to prevent relapse and metastasis.

OverviewStructured DataIssuesContributors

Contents

hibercell.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Oncology
Oncology
Engineering
Engineering
Cancer
Cancer
Therapeutics
Therapeutics
Medical diagnostics
Medical diagnostics
Biomedical engineering
Biomedical engineering
Biotechnology
Biotechnology
...
Location
New York City
New York City
New York
New York
B2X
B2B
B2B
0
Founder
‌
Alan Rigby, Ph.D.
‌
Ari Nowacek, M.D., Ph.D.
‌
Julio Aguirre-Ghiso, Ph.D.
Number of Employees (Ranges)
51 – 2000
Full Address
619 West 54th Street, 8th Floor, New York, New York 10019, US0
Investors
Bristol-Myers Squibb
Bristol-Myers Squibb
ARCH Venture Partners
ARCH Venture Partners
Founded Date
2019
Total Funding Amount (USD)
128,150,000
Latest Funding Round Date
May 19, 2021
Latest Funding Type
Series B
Series B
Patents Assigned (Count)
1
Country
United States
United States

Other attributes

Company Operating Status
Active

HiberCell is a biotechnology company that develops therapeutics for the prevention of relapse and metastasis. It is a company that focuses exclusively on therapeutically modulating the biology and mechanisms of tumor dormancy. The company is developing therapeutics that target dormant disseminated tumor cells from solid and liquid cancers and the company has the goal of preventing or delaying the recurrence of cancer.

The company was launched based on the research that was carried out at Mount Sinai’s Tisch Cancer Institute which shows that cancer recurrence is driven by dormant disseminated tumor cells, or DTCs, that can persist in the body for long period of time. The company aims to approach cancer as a systemic disease, detect and target DTCs to prevent or delay metastasis.

HiberCell is committed to developing therapeutic molecules that overcome foundational scientific barriers which prevent patients from living longer and ensure people live cancer-free. HiberCell has a multidisciplinary team that consists of cancer scientists, drug developers and venture capitalists who are leaders in their respective fields.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like HiberCell

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.